chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Right arm swelled up in tricep area to size of an apple. Accompanied by tenderness and rash.
Swelling/ tingling on left side face and base of Tongue; Swelling/ tingling on left side face and base of Tongue; Swelling/ tingling on left side face and base of Tongue; Swelling/ tingling on left side face and base of Tongue; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 59 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Jan2022 09:00 (Batch/Lot number: unknown) at the age of 59 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Arthritis" (unspecified if ongoing); "Allergic to lobster" (unspecified if ongoing), notes: Known allergies: Compazine, Champagne and lobster together; "Allergic to Champagne" (unspecified if ongoing), notes: Known allergies: Compazine, Champagne and lobster together. Concomitant medication(s) included: MOTRIN [IBUPROFEN]. Past drug history included: Compazine, reaction(s): "Known allergies: compazine, Champagne and lobster together", notes: Known allergies: Compazine, Champagne and lobster together. The following information was reported: PARAESTHESIA (non-serious), SWELLING FACE (non-serious), PARAESTHESIA ORAL (non-serious), SWOLLEN TONGUE (non-serious) all with onset 11Jan2022 11:00, outcome "recovering" and all described as "Swelling/ tingling on left side face and base of Tongue". Therapeutic measures were taken as a result of paraesthesia, swelling face, paraesthesia oral, swollen tongue. Additional information: Patient did not receive any other vaccine in four weeks. Patient received other medications in two weeks which included Motrin. Patient experienced swelling/tingling on left side face and base of Tongue on 11Jan2022 at 11:00. Patient received treatment for the adverse events which included Benadryl. Patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination.   The lot number for bnt162b2 was not provided and will be requested during follow up.
The pt had varicella vaccination on 10/13/99 and started to have chickenpox rash on 12/31/01. Treatment includes Benadryl and local skin care.
Stomach ache w/ diarrhea: started about 12 hours after vaccination and last for approximately 3 hours Body Aches/joint pains: started about 14 hours after vaccination and last approximately 36 Exhaustion: started about 14 hours after vaccination and lasted approximately 48 hours  Large red "goose egg" that was warm to touch at the site of injection: started about 24 hours after vaccination and lasted approximately 52 hours Sore arm: started about 12 hours after vaccination and lasted approximately 52 hours
hypersensitivity reaction with rash with diffuse erythema, swelling of hands and feet
10/10/15 STARTED HAVING A LITTLE DISCOMFORT AND HARDENING TO RIGHT AC AREA, ON 10/11/15 AREA BECAME REDDENED/ITCHY, AND ENLARGED, DONOR PRESENTED TO CENTER TODAY 10/12/15 AREA HARDENED ABOUT 2 INCHES, SKIN REDDENED ABOUT 3 INCHES IN DIAMETER AND TENDER TO PALPATION AND ITCHY, DONOR ENCOURAGED TO VISIT DOCTOR FOR EVALUATION AND TREATMENT.
didn't mention a 2nd shot and did not follow up to give me one.; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 1st February 2021, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. In September 2021, between 7 and 8 months after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shingles. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the shingles and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received 1st dose of Shingrix vaccine and had contracted shingles.  The patient's doctor did not mention a 2nd dose and did not follow up to give him/her one, and till the time of reporting, the patient did not receive 2nd dose, which led to incomplete course of vaccination. The patient asked what the recommendation was on what he/she should do now. The follow-up would not possible as no contact details were available.
pt recv vax 13FEB98 & approx 27FEB98 pt devel chickenpox;
Starting this morning, I feel lousy: aches, chills, malaise. Some tenderness at the injection site.  Same reaction as the first shot, received in late April 2018.
This spontaneous report as received from a Nurse refers to an unspecified number of patients. The Nurse reported that a medical office might had administered GARDASIL (lot # unspecified), injection which may have under went an unsupported excursion, to an unspecified number of patients. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report as received from a Health care worker pharmacy technician refers two patients of unknown age and gender. On an unknown date, the patient was vaccinated with RECOMBIVAX HB (lot # J007329 27-MAR-2015) 1 pediatric dose (dose and route not provided) and RECOMBIVAX HB (lot # J009049 exp 27-MAR-2015) 1 pediatric dose (dose and route not provided). Health care worker (pharmacy technician) stated that two patients may have received vaccine (dose and dose in series unspecified) that were improperly stored on 28-FEB-2014 at 9.5C for 50 minutes. No adverse effects reported. The outcome of incorrect product storage was unknown. This is one of several reports from same source. Additional information has been requested.
Started to experience achiness, headache the next day & increased achiness with fever & headache on Tuesday. Wednesday: Eyes sensitive to light, increased headache, achiness, nasal drainage, no nausea, or vomiting.  Wednesday evening temp 102.8, with weakness, fatigue, achiness, sensitivity to light all increasing.
no adverse effects reported; an unspecified patient with date of birth 7/31/2016, received a dose of MMR II (M035388, expiration 8/2/2018) on 7/25/2017 "5 days before they turned one year old"; Information has been received from a nurse referring to a 11 months old patient with unknown gender. The patient's concomitant drug included sterile diluent. The patient's pertinent medical history, drug reactions or allergies were not reported.  On 25-JUL-2017 (5 days before turning one year old), the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (lot number: M035388; expiration date: 02-AUG-2018; strength and route were not reported) for prophylaxis (Inappropriate age at vaccine administration). No adverse effects reported. The outcome of the event was unknown.
Patient reported a rash over trunk arms and legs after injection (onset 24 hours after injection) still present 2 days after so went to MD and prescribed ointment. Ointment Benadryl cleared rash on 8-11-06.
This case was reported by a pharmacist via call center representative and described the occurrence of contusion in a 65-year-old female patient who received FLUARIX quadrivalent (batch number 329TN, expiry date 30th June 2016. In October 2015, the patient received FLUARIX quadrivalent .5 ml. On 6th October 2015, less than a week after receiving FLUARIX quadrivalent, the patient experienced contusion. On an unknown date, the outcome of the contusion was unknown. It was unknown if the reporter considered the contusion to be related to FLUARIX quadrivalent. Additional details were provided as follows: In October 2015, one week before the time of reporting, the patient received FLUARIX QIV. The patient experienced a large bruise (contusion) which was black or purple in colour after the vaccination. The healthcare professional reported that the patient came back to the doctor's office to report the adverse reaction experienced by her. The healthcare professional wanted to know the additional information or studies of the similar symptoms.
With oin 10 hours I began to have extreme chills (no sweating) which lasted 8 hours, dizziness upon rising from bed, and a temperature of 103 degrees F that lasted 9 hours.  I did not report these to my doctor, but I did cancel an appointment with a doctor who was going to review CT scan results with me.
rash all over trunk; patient experienced 101 F. fever; chills; flushing; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (flushing), RASH (rash all over trunk), PYREXIA (patient experienced 101 F. fever) and CHILLS (chills) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concomitant products included OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced FLUSHING (flushing), PYREXIA (patient experienced 101 F. fever) and CHILLS (chills). On 12-Feb-2021, the patient experienced RASH (rash all over trunk). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FLUSHING (flushing), RASH (rash all over trunk), PYREXIA (patient experienced 101 F. fever) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Feb-2021, Heart rate: elevated (Inconclusive) Elevated.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Provider Summary: Patient is a 86 YO year old male with a PMH of Seizure disorder on phenytoin, vascular dementia, chronic dysarthria, right hemiparesis, HTN, and HLD who presented to Hospital after having a witnessed seizure. Throughout the stay, Pt was unable to participate meaningfully in conversation. His phenytoin level was found to be low. Neurology was consulted and they recommended adding Keppra 500 mg BID. Pt did not have additional seizures while inpatient. Per discussion with Neurology team, will increase Phenytoin to 400 mg QD after discharge, as his Dilantin level was consistently subtherapeutic.    His blood cultures from admission showed 2/2 staph hominis and he was started on Vancomycin on 1/15. 1/2 Repeat blood culture was positive, but it grew Staph epi. On the day of discharge, the Hospitalist team discussed with Infectious Disease who agreed that it was likely not a true bacteremia, as the cultures both showed 2 strains of staph hominis without the Pt showing signs of systemic infection so the decision was made to not give antibiotics after discharge. Discussed with Pt's guardian regarding his scrotal enlargement and large right inguinal hernia seen on CT and she was agreeable to referral to General Surgery for hernia repair.    Of note, he was noted to have COVID-19 infection with mild hypoxia requiring 2L NC on admission, which resolved on 1/15 and he stopped requiring oxygen.    Discharged to the living facility in stable condition. "
muscle pain was in a site she had injured several times back prior to the vaccine; has been tired or last; hiatal hernia and this has made it worse; Chills; redness and pain at injection site; redness and pain at injection site; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 84-years-old female patient received bnt162b second dose of BNT162B2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch number/Lot number was unknown), via an unspecified route of administration, administered in arm left on 22Feb2021 (Age at vaccination 84-years-old) as dose 2, single for covid-19 immunization. Medical history included chronic obstructive pulmonary disease, chronic bronchitis, breast cancer from an unknown date and unknown if ongoing. There were no concomitant medications. Patient received first dose of BNT162B2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch number: not reported/Lot number: EL3247), via an unspecified route of administration, administered in arm left on 25Jan2021 (Age at vaccination 84-years-old) as dose 1, single for covid-19 immunization. On 22Feb2021, the patient experienced redness and pain at injection site. On 23Feb2021, the patient experienced chills. On 24Feb2021, the patient experienced hiatal hernia and this has made it worse. On an unspecified date the patient experienced muscle pain was in a site she had injured several times back prior to the vaccine, has been tired or last. Caller stated she was looking at the side effects, had the redness at injection site pain, only hurts if she lays down on it, tries to stay away from that, got the redness around it, somethings have gone away, had real bad chills last night, muscle pain was in a site she had injured several times back prior to the vaccine, hiatal hernia and this has made it worse, has been tired or last. The patient underwent lab tests and procedures which included weight was 150-154 lbs it goes up and down on an unspecified date. The clinical outcome of the events redness and pain at injection site, hiatal hernia and this has made it worse was not recovered. Chills was recovered on 23Feb2021. For the events muscle pain was in a site she had injured several times back prior to the vaccine, has been tired or last outcome was unknown.   Follow-up attempts are completed. No further information is expected.
Had shingles had the shot/Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had shingles had the shot/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 17-MAR-2023 This case was reported by a consumer via interactive digital media. The reporter stated that every person he/she knew who had shingles and had the shingles shot. The reporter further stated that people needed to stop trusting shingles shots poison. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Information has been received from a physician concerning a patient (age and gender unknown), who on 19-JUL-2007 was vaccinated with a dose of Gardasil. On 20-JUL-2007 the patient experienced fever and diarrhea. The diarrhea has resolved. The patient continued to experience persistent fever, malaise, and a headache. The patient has taken MOTRIN every 4 to 6 hours "around the clock." The patient was sent to the emergency room for a spinal tap. No product quality complaint was involved. Additional information has been requested.
Information has been received from a physician, via company representative, referring to a patient of unknown age and gender. The patient's  medical history, concomitant therapies and concurrent conditions were not provided. On unknown dates, the patient was vaccinated with  2 doses of VARIVAX (lot/batch #, expiration date, route of administration and dose were not provided) for prophylaxis, and subsequently had negative varicella titers (antibody test negative). At the time of the report the outcome of antibody test negative was unknown. The reporting physician did not rate the causality assessment between the Antibody test negative and VARIVAX. Additional information is not expected since the physician refused to be contacted.
SKIN REACTION ON BOTH ARMS THAT LOOKS GHASTLY; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A expiry: UNKNOWN) dose was not reported, administered on 16-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 16-JUL-2021, the patient experienced skin reaction on both arms that looks ghastly. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from skin reaction on both arms that looks ghastly. This report was non-serious.
After patient receiving covid 19 pfizer vaccine, 5-8 minutes later he complained that he is hot, showed light sweating, and his skin color was pale. He was alert and kept saying  he is  " hot".  He was sitting on the floor when pharmacist was out to check on him, and later he laid on the floor while he was alert. I asked him if he needs more assistant or call 911, he declined ( he is minor and his mom was next to him).  Pharmacy staff gave him water and ice pack. After 3-4 minutes later of drinking water he was getting more alert and able to sit on the chair himself. I told patient to wait 15 more minutes. As he drink more water patient was getting better,hi mom said " he is better" , and left pharmacy with his mom.
Severe tongue swelling, burning and redness that started 2 days after the 2nd dose of Pfizer vaccine. It was followed by increased tongue pigmentation involving the anterior third of the tongue. It has been slowly getting better over the last 3 months but still not at baseline. Residual symptoms include change in taste, pigmentation and burning with spicy foods.
0.1 ML OF VACCINE ADMINISTERED BEFORE WHEAL APPEARED ON SKIN. VACCINE ADMINSRATION STOPPED. WHEAL MEASURED AT 1 CM WITH 7.5 CM BORDER AT 15 MIN POST VACCINATION. CERTRIZINE 2.5 ML ADMINSTERED. WHEAL DECREASED TO 0.5 CM AND 1.5 CM ERYTHEMA BORDER AT 45 MIN POST VACCINE ADMINISTRATION. PATIENT LEFT AT 1 HOUR POST VACCINE ADMINISTRATION WITH WHEAL AND BORDER DECREASED SIGNIFICANTLY.
The day after immunization expected local pain but then gradually progresses to diffuse joint pain/stiffness and swelling.  Has been slowly improving.
This was my 2nd dosage of the shot.  The first shot, I had NO side effects.  With this, the  2nd shot, I experienced:  FLUSHING; FEVER; SLIGHT CHILLS; PAIN @ INJECTION SITE; SORE MUSCLE IN ARM; EXTREMELY HIGH BLOOD PRESSURE & PULSE (B/P WAS 190/90 & PULSE WAS 88 & WHEN TAKEN A FEW MINUTES LATER IT WAS: 188/88 & PULSE WAS 89); HEART WAS FEELING HEAVY; NO ENERGY, NO STAMINA, SLEPT ON AND OFF ALL DAY; AND HEADACHE (LIKE A MIGRAINE ).
Local reaction to DTaP characterized by redness (3 by 4 cm), induration (2.5 by 2.5 cm) and itching.  There were no systemic reaction or sx or sn.
Felt hot within a few minutes after the vaccine, then passed out. The NP on site said she was unable to find a pulse so did 10 chest compressions before I woke up. Called the rescue squad who did an EKG on route to Hospital and once I was in the ER another EKG was performed along with blood work and chest X-ray. Entry was noted as allergic reaction but diagnosis was noted as Vasovagal Syncope, Adult. EKG?s performed along with labs were normal. I have pulled muscles, tendons and ligaments from the chest compressions which were questionable but since that day have experienced tingling in upper body and arms and have felt bad. Went back to my Primary Care Doctor for follow up on March 29 for another EKG. Have had panic attacks from the situation and per Doctor will take 2 months for my chest, muscles, tendons and ligaments to heal. Hard to determine if the way I have felt is from the vaccine or what transacted when I fainted. Today which is April 9, I still feel weak, normally I am very energetic. Just wanted to report as when I saw the news that others had some situations thought best to let you know.
pop up clinic at local meat packing plant.  patient c/o of feeling Hot, dizzy 10-15 minutes post injection. unable to stand without dizziness. actions taken - cold compress, feet elevated, water 12-16 oz, juice 12 once.  patient continued to c/o dizziness . 911 called by staff at 1030 - BP 168/90, pulse 98
SC injection of PNEUMOVAX 23 / 1 25mcg / 0.5 ml Merck NDC 00006-4943-00 11:15 am on 8/23 - got vaccine, came in on 8/24 with swelling and redness over arm spreading over whole area. Felt tired and sore.
Hypotension - possible sepsis, Acute Kidney Injury, Hyperbilrubinemia, RUQ abdominal pain, Chest pain IV fluids,  Ceftriaxone x 48 hours. RUQ ultrasound - normal.
SORE ARM; This spontaneous report received from a patient concerned a 72 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 180503, and expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sore arm was not reported. This report was non-serious.
Admitted for COVID-19 pna; worsening resp failure required intubation; also tx w/remdesivir, abx, steroids, zinc; pt extubated and weaned to RA; dc'd to home w/HHC
8 to 12 hours after my first COVID-19 shot on 3/11, the outside of my left (non dominant ) wrist started to hurt. I had not injured or overused it. It has never hurt without a reason before. It has continued to hurt ever since (47 days). That was the only side effect I had other than a sore upper left arm (several days). Nothing changed after my second shot (lot #EP7533) on 4/11 (just a sore upper left arm again for several days). The pain has spread to the inside/underside of my wrist in the last week or so.
Severe headache, high fever(104.5), chills, body aches, joint and muscle pain. Onset of symptoms did not occur immediately. Mild (typical) post vaccination pain at injection site about 8 ot 9 hours after administration. Went to sleep without any systemic symptoms and woke up about 12 hours after administration with fever and chills. Temp approximately 101.5 at this point and chills body aches were moderate. Then woke up another 4 hrs later with severe headache, chills, weakness, joint and muscle pain and high fever(104.5). Symptoms have all begun to gradually improve, but still febrile with all other symptoms not being moderate and not severe, 26 hrs post vaccine administration.
After HPV and MCV vaccines were given in the left upper arm, patient started crying and complaining of numbness and weakness in left arm, he had weakness and numbness only for 10 min, he was observed in the office for 30 - 40 min after all the vaccines were given. At the time of the d/c he was able to move his left arm well, ROM was nl, normal strength, normal sensation; he denied H/A, dizziness. The reaction to vaccines will be reported to VAERS, the message was left today. We followed up with the family within 48 hrs, patient didn't have any numbness, had full strength  in his left arm. Per MD notes.
PATIENT GOT VERY DIZZY AND LIGHTHEADED AFTER VACCINE.  ALSO STARTED SWEATING PROFUSELY.  GAVE ORANGE JUICE AND WATER.  SYMPTOMS RESOLVED AFTER A FEW MINUTES.